Interim Position Statement: Inhaled budesonide for adults (50 years and over) with COVID-19

Document first published:
Page updated:
Topic:
,
Publication type:

The PRINCIPLE trial has reported a 3-day median benefit in self-reported recovery for patients with COVID-19 in the community setting who received inhaled budesonide.